Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive. 1982

D A Staunton, and P J Magistretti, and G F Koob, and W J Shoemaker, and F E Bloom

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003714 Denervation The resection or removal of the nerve to an organ or part. Laser Neurectomy,Neurectomy,Peripheral Neurectomy,Radiofrequency Neurotomy,Denervations,Laser Neurectomies,Neurectomies,Neurectomies, Laser,Neurectomies, Peripheral,Neurectomy, Laser,Neurectomy, Peripheral,Neurotomies, Radiofrequency,Neurotomy, Radiofrequency,Peripheral Neurectomies,Radiofrequency Neurotomies
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006892 Hydroxydopamines Dopamines with a hydroxy group substituted in one or more positions. Hydroxydopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm

Related Publications

D A Staunton, and P J Magistretti, and G F Koob, and W J Shoemaker, and F E Bloom
January 1980, Communications in psychopharmacology,
D A Staunton, and P J Magistretti, and G F Koob, and W J Shoemaker, and F E Bloom
November 1973, Neuropharmacology,
D A Staunton, and P J Magistretti, and G F Koob, and W J Shoemaker, and F E Bloom
May 1975, Psychopharmacologia,
D A Staunton, and P J Magistretti, and G F Koob, and W J Shoemaker, and F E Bloom
January 1975, Advances in neurology,
D A Staunton, and P J Magistretti, and G F Koob, and W J Shoemaker, and F E Bloom
November 1975, National Institute on Drug Abuse research monograph series,
D A Staunton, and P J Magistretti, and G F Koob, and W J Shoemaker, and F E Bloom
October 1978, Life sciences,
D A Staunton, and P J Magistretti, and G F Koob, and W J Shoemaker, and F E Bloom
January 1987, Alcohol and drug research,
D A Staunton, and P J Magistretti, and G F Koob, and W J Shoemaker, and F E Bloom
January 1982, Life sciences,
D A Staunton, and P J Magistretti, and G F Koob, and W J Shoemaker, and F E Bloom
January 1981, The Journal of physiology,
D A Staunton, and P J Magistretti, and G F Koob, and W J Shoemaker, and F E Bloom
March 2006, Behavioural pharmacology,
Copied contents to your clipboard!